Ionsys

RSS

Withdrawn

This medicine's authorisation has been withdrawn

fentanyl
MedicineHumanWithdrawn

Irish is available via eTranslation, the European Commission's machine translation service.

Translate to Irish | Important information about machine translation

  • Application under evaluation
  • CHMP opinion
  • European Commission decision

Overview

On 24 January 2006 the European Commission granted a marketing authorisation for the whole European Union to Janssen-Cilag International N.V. for Ionsys (fentanyl), a iontophoretic transdermal system to deliver fentanyl transdermally, to be used for the management of acute moderate to severe post-operative pain for use in a hospital setting only. In January 2009 the European Commission issued a decision for suspension of the marketing authorization of Ionsys for quality related issues. 

Ionsys has not been marketed in Europe since October 2008. The Marketing Authorisation Holder did not apply to renew the marketing authorisation. Consequently, the five-year marketing authorization for Ionsys expired on 24 January 2011. 

Pursuant to this decision the European Public Assessment Report for Ionsys is updated to reflect that the marketing authorisation is no longer valid.

български (BG) (908.71 KB - PDF)

Amharc

español (ES) (699.86 KB - PDF)

Amharc

čeština (CS) (857.78 KB - PDF)

Amharc

dansk (DA) (699.95 KB - PDF)

Amharc

Deutsch (DE) (703.23 KB - PDF)

Amharc

eesti (ET) (696.29 KB - PDF)

Amharc

ελληνικά (EL) (909.83 KB - PDF)

Amharc

français (FR) (764.31 KB - PDF)

Amharc

italiano (IT) (700.75 KB - PDF)

Amharc

latviešu (LV) (865.66 KB - PDF)

Amharc

lietuvių (LT) (819.47 KB - PDF)

Amharc

magyar (HU) (848.47 KB - PDF)

Amharc

Malti (MT) (865.33 KB - PDF)

Amharc

Nederlands (NL) (700.41 KB - PDF)

Amharc

polski (PL) (867.88 KB - PDF)

Amharc

português (PT) (701.3 KB - PDF)

Amharc

română (RO) (811.56 KB - PDF)

Amharc

slovenčina (SK) (855.01 KB - PDF)

Amharc

slovenščina (SL) (1.06 MB - PDF)

Amharc

suomi (FI) (699.92 KB - PDF)

Amharc

svenska (SV) (699.09 KB - PDF)

Amharc

Product information

Latest procedure affecting product information:A20-0013
24/01/2011
icon globe

This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

български (BG) (337.27 KB - PDF)

Amharc

español (ES) (271.55 KB - PDF)

Amharc

čeština (CS) (294.66 KB - PDF)

Amharc

dansk (DA) (274.05 KB - PDF)

Amharc

Deutsch (DE) (277.24 KB - PDF)

Amharc

eesti (ET) (271.11 KB - PDF)

Amharc

ελληνικά (EL) (296.32 KB - PDF)

Amharc

français (FR) (273.91 KB - PDF)

Amharc

italiano (IT) (271.94 KB - PDF)

Amharc

latviešu (LV) (296.23 KB - PDF)

Amharc

lietuvių (LT) (293.06 KB - PDF)

Amharc

magyar (HU) (273.95 KB - PDF)

Amharc

Malti (MT) (306.85 KB - PDF)

Amharc

Nederlands (NL) (273.18 KB - PDF)

Amharc

polski (PL) (294.54 KB - PDF)

Amharc

português (PT) (273.3 KB - PDF)

Amharc

română (RO) (309.43 KB - PDF)

Amharc

slovenčina (SK) (285.33 KB - PDF)

Amharc

slovenščina (SL) (291.9 KB - PDF)

Amharc

suomi (FI) (270.57 KB - PDF)

Amharc

svenska (SV) (273.4 KB - PDF)

Amharc

español (ES) (444.81 KB - PDF)

Amharc

čeština (CS) (530.11 KB - PDF)

Amharc

dansk (DA) (442.46 KB - PDF)

Amharc

Deutsch (DE) (445.69 KB - PDF)

Amharc

eesti (ET) (444.98 KB - PDF)

Amharc

ελληνικά (EL) (541.07 KB - PDF)

Amharc

français (FR) (444.97 KB - PDF)

Amharc

italiano (IT) (444.55 KB - PDF)

Amharc

latviešu (LV) (535.95 KB - PDF)

Amharc

lietuvių (LT) (513.78 KB - PDF)

Amharc

magyar (HU) (499.52 KB - PDF)

Amharc

Nederlands (NL) (448.25 KB - PDF)

Amharc

polski (PL) (532.63 KB - PDF)

Amharc

português (PT) (446.1 KB - PDF)

Amharc

slovenčina (SK) (527.9 KB - PDF)

Amharc

slovenščina (SL) (523.29 KB - PDF)

Amharc

suomi (FI) (445.17 KB - PDF)

Amharc

svenska (SV) (444.15 KB - PDF)

Amharc

Product details

Name of medicine
Ionsys
Active substance
fentanyl hydrochloride
International non-proprietary name (INN) or common name
fentanyl
Therapeutic area (MeSH)
Pain, Postoperative
Anatomical therapeutic chemical (ATC) code
N02AB03

Pharmacotherapeutic group

Analgesics

Therapeutic indication

Management of acute moderate to severe post-operative pain for use in a hospital setting only

Authorisation details

EMA product number
EMEA/H/C/000612
Marketing authorisation holder
Janssen-Cilag International NV

Turnhoutseweg, 30
B-2340 Beerse
Belgium

Marketing authorisation issued
24/01/2006
Withdrawal of marketing authorisation
24/01/2011
Revision
3

Assessment history

This page was last updated on

Share this page